Saving changes...

Done

Error

Pipeline Drugs in Oral Chemotherapy

Pipeline Drugs in Oral Chemotherapy

Pipeline Drugs in Oral Chemotherapy

Brian Cochran, PharmD, BCOP
Brian Cochran, PharmD, BCOP
on behalf of Specialty Pharma Education Center

$7.99 $ 7.99 $ 7.99

$7.99 $ 7.99 $ 7.99

$ 7.99 $ 7.99 $ 7.99
$ 7.99 $ 7.99 $ 7.99
Normal Price: $7.99 $7.99

Review:

Launch date: 07 Jul 2016

Expiry Date: 13 Aug 2018

Last updated: 26 Oct 2017

Reference: 163601

Exam is embedded in the course
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

A comprehensive course on Pipeline Drugs in Oral Chemotherapy

Faculty Disclosures:
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Objectives

After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, and Chief Pharmacy Officers along with other healthcare practitioner participants will be able to:
1. Recognize the unmet needs in the current treatment strategies for oral oncology
2. Describe the major outcomes used in clinical trials of emerging therapies in oral oncolytics
3. Review the similarities and differences of new classes of emerging and future therapies
4. Discuss the evolving risk/benefit profile of these new agents and the monitoring that they will warrant
Brian Cochran, PharmD, BCOP

Author Information Play Video Bio

Brian Cochran, PharmD, BCOP
on behalf of Specialty Pharma Education Center

Brian Cochran, PharmD, BCOP
Oncology Pharmacist Coordinator
IU Simon Cancer Center, IU Health

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Reference number: 0535-0000-15-010-H01-P

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error